ELEDON PHARMACEUTICALS INC
ELDN · NASDAQ
更新於 2026-10-15 04:16:09
$2.25-3.84%
- 今日最高
- $2.36
- 今日最低
- $2.22
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $2.31
- 昨天收盤價
- $2.25
- 成交量
- 987.5K
- 市值
- $198.27M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.96
昨天價格區間
$2.22$2.36
52週價格區間
$1.35$4.60
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 19800 MACARTHUR BOULEVARD, IRVINE, CA, UNITED STATES, 92612
- 國家
- 美國
- 上市日期
- 2014-09-17
- 財年截止
- 十二月
- 流通股數
- 77.19M
- CIK
- 0001404281
- 官方網址
- eledon.com
Eledon Pharmaceuticals, Inc. 是一家臨床階段生物製藥公司，專注於為需要器官或細胞移植的自身免疫性疾病及肌萎縮性側索硬化症（ALS）患者開發藥物。公司總部位於加利福尼亞州爾灣。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
營業支出
2026-06-30
$22.86M
2026-03-31
$21.18M
2025-12-31
$21.48M
2025-09-30
$19.07M
淨利潤
2026-06-30
-$31.63M
2026-03-31
-$39.02M
2025-12-31
-$10.44M
2025-09-30
-$17.45M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.19
2026-03-31
$-0.33
2025-12-31
$-0.10
2025-09-30
$-0.21
息稅折舊攤銷前利潤
2026-06-30
-$14.1M
2026-03-31
-$39.02M
2025-12-31
-$10.33M
2025-09-30
-$17.45M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
-0.33%
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $0 | $0 | $0 | $0 |
| 營業支出 | $22.86M | $21.18M | $21.48M | $19.07M |
| 淨利潤 | -$31.63M | -$39.02M | -$10.44M | -$17.45M |
| 淨利潤率 | -- | -- | -- | -- |
| 每股收益 | $-0.19 | $-0.33 | $-0.10 | $-0.21 |
| 息稅折舊攤銷前利潤 | -$14.1M | -$39.02M | -$10.33M | -$17.45M |
| 有效稅率 | -- | -- | -0.33% | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。